Markóczy Zsolt and Sárosi Veronika and Kudaba Iveta and Gálffy Gabriella and Turay Ülkü Yilmaz and Demirkazik Ahmet and Purkalne Gunta and Somfay Attila and Pápai-Székely Zsolt and Rásó Erzsébet and Ostoros Gyula:
Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial.
BMC CANCER, 18 (1).
Azonosító: 598-Terjedelem: 7 p.
ISSN 1471-2407
(2018)